SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 81 filers reported holding SUTRO BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217 | +4.8% | 62,579 | +40.7% | 0.00% | – |
| Q2 2023 | $207 | -63.0% | 44,486 | -63.3% | 0.00% | – |
| Q1 2023 | $559 | -15.4% | 121,144 | +47.9% | 0.00% | – |
| Q4 2022 | $661 | -99.4% | 81,899 | +300.9% | 0.00% | – |
| Q3 2022 | $114,000 | -8.8% | 20,429 | -14.3% | 0.00% | – |
| Q2 2022 | $125,000 | -71.7% | 23,838 | -55.5% | 0.00% | – |
| Q1 2022 | $441,000 | -95.8% | 53,591 | -92.4% | 0.00% | -100.0% |
| Q4 2021 | $10,546,000 | +68.8% | 708,774 | +114.4% | 0.00% | -33.3% |
| Q3 2021 | $6,247,000 | +40.6% | 330,624 | +38.3% | 0.00% | +50.0% |
| Q2 2021 | $4,443,000 | -24.9% | 238,994 | -8.1% | 0.00% | -33.3% |
| Q1 2021 | $5,919,000 | +18.5% | 260,123 | +13.0% | 0.00% | 0.0% |
| Q4 2020 | $4,995,000 | +107.9% | 230,119 | -3.8% | 0.00% | +200.0% |
| Q3 2020 | $2,403,000 | +30.5% | 239,125 | +0.7% | 0.00% | 0.0% |
| Q2 2020 | $1,841,000 | -21.5% | 237,359 | +3.2% | 0.00% | -50.0% |
| Q1 2020 | $2,346,000 | +1061.4% | 229,941 | +1156.6% | 0.00% | – |
| Q4 2019 | $202,000 | +74.1% | 18,299 | +43.7% | 0.00% | – |
| Q3 2019 | $116,000 | +4.5% | 12,732 | +30.9% | 0.00% | – |
| Q2 2019 | $111,000 | +428.6% | 9,726 | +438.5% | 0.00% | – |
| Q1 2019 | $21,000 | +133.3% | 1,806 | +80.8% | 0.00% | – |
| Q4 2018 | $9,000 | – | 999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |